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ABSTRACT	 	The	current	study	is	to	develop	the	acute	and	sub-acute	toxicity	profile	of	some	ayurvedic	Bhasma	and	un-derstand	the	side	effects	due	to	the	presence	of	heavy	metals.	Chandraprabha	vati	pill	were	weighed,	pow-dery	and	suspended	in	water	had	made	into	liquid	formulation.	The	animals	were	classified	and	treated	with	the	doses	of	Chandraprabha	vati	(50and	five	hundred	mg/kg)	in	rat.	The	dose	was	calculated	by	extrapolat-ing	the	equivalent	human	dose	(1	and	ten	times)	and	was	administered	orally	between	ten	and	eleven	after	median	daily	for	28	days,	during	all	 in	a	very	volume	not	exceeding	one	ml/100	g	rat	weight.	Blood	was	collected	on	7,	14	and	28	days,	later	they	were	sacrificed	for	histopathological	studies.	 	  
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INTRODUCTION	Bhasma	are	distinctive	 ayurvedic	metallic/minerals	preparation,	 treated	with	 herbal	 juice	 or	 decoction	and	exposed	for	Ayurveda,	that	are	best-known	in	In-dian	 landmass	 since	 7thcentury	 A.D.	 and	 wide	 sug-gested	for	treatment	of	a	variety	of	chronic	ailments.	Animal's	by-product	like	horns,	shells,	feathers,	me-tallic,	non-metallic	and	herbals	are	normally	admin-istered	as	Bhasma.	Bhasma	that	contain	iron,	Cu,	S	or	different	 producing	 method	 plays	 a	 particular	 role	within	the	final	product.	Standardization	of	Bhasma	is	utmost	necessary	to	substantiate	its	identity	and	to	see	its	quality,	purity	safety,	effectiveness	and	accept-ableness	of	the	product.	However,	the	most	necessary	challenges	baby-faced	by	these	formulations	are	the	
shortage	 of	 complete	 standardization	 by	 physio-chemical	parameters.	
Complications	and	toxic	effects	of	in	toxification	There	 is	a	 section	 in	Ayurveda	 referred	 to	as	 “Rasa	shastra”	 that	 describes	 the	 employment	 of	 metals,	gems,	minerals	and	poisons	for	producing	special	for-mulations	 to	 combat	 chronic	 and	 tough	 diseases.	Rasa	Shastra	is	referred	to	as	“Vedic	Chemistry”.	As	the	modern	 laboratory	chemicals	were	not	 fictional	within	 the	 vedic	 era	 (3000	 years	 ago),	 seasoning	juices	were	used	instead.	largely	made	of	metal	ashes	those	 are	 referred	 to	 as	 rasa	 product,	 Saini	 says.	These	 medicines,	 additionally	 called	 bhasmas,	 take	off	 of	 associate	 ayurvedic	 tradition	 practiced	 for	thousands	of	years	in	India	wherever	extremely	cyto-toxic	 serious	metals	 like	 lead,	 arsenic,	mercury	and	atomic	number	48	combine	with	herbs	or	spices.	se-rious	metal	toxicity	following	the	utilization	of	Ayur-vedic	remedies	is	well	documented	within	the	litera-ture	(11).	
	 	
Figure 1: Brands of chandraprabha vati	During	 the	 standard	 preparation	 of	 bhasmas	 the	metal	is	“purified-out”	through	multiple	cooling	and	heating	 cycles	 and	 by	 addition	 of	 specific	 “mineral	
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herbs”.	 In	modern	 formulations,	 however,	 the	 con-centration	of	serious	metals	could	also	be	excessive	as	a	result	of	poor	quality	control	permits	for	contam-ination,	adulteration,	or	improper	purification.	2	re-cent	Canadian	province	cases	highlight	the	attainable	danger	of	taking	Ayurvedic	remedies.	A	male	given	to	hospital	feeling	terribly	sick	with	em-esis	 and	 looseness	 of	 the	 bowels.	 His	 bloodwork	showed	 solution	 abnormalities	 and	 anemia	 with	stainability	stippling	of	his	red	blood	cells.	for	a	few	years	he	had	been	 taking	one	pill	daily	of	associate	Ayurvedic	medication	purchased	in	India	to	“increase	vigor”.	 His	 blood	 lead	 level	 was	 5.2µmol/L.	 Heavy	metal	analysis	showed	that	every	pill	contained	some	28	mg	of	lead,	0.70	mg	mercury,	0.11	mg	arsenic,	and	negligible	amounts	of	cadmium.	He	responded	well	to	succimer	chelation	with	no	apparent	sequelae	(11).	
Bhasmas	required	detoxification	In	 preparations	 of	 those	 Bhasmas,	 the	 preliminary	method	that	causes	detoxification	while	not	harming	its	 medicative	 properties	 (guṇas)	 is	 named	 as	 So-dhana	(12).	the	method	of	sodhana	was	well	accepted	by	the	pioneers	of	Rasasastra	for	the	purification	of	herbomineral	medicine.	These	ways	were	developed	to	 detoxify	 the	 staple	 by	 chemical	 transformations	and	 enhance	 the	 properties	 and	 therapeutic	 poten-tial.	There	are	issues	raised	concerning	the	utilization	of	metals	and	minerals	in	therapeutics.	Raising	safety	issues	 regarding	 ancient	 preparations,	 the	 World	Health	Organization	has	 issued	pointers	concerning	toxicity	studies	of	seasoning	medicine	(13).	
Bhasmas	required	detoxification	In	 preparations	 of	 those	 Bhasmas,	 the	 preliminary	method	that	causes	detoxification	while	not	harming	its	 medicative	 properties	 (guṇas)	 is	 named	 as	 So-dhana	(12).	the	method	of	sodhana	was	well	accepted	by	the	pioneers	of	Rasasastra	for	the	purification	of	herbomineral	medicine.	These	ways	were	developed	to	 detoxify	 the	 staple	 by	 chemical	 transformations	and	 enhance	 the	 properties	 and	 therapeutic	 poten-tial.	There	are	issues	raised	concerning	the	utilization	of	metals	and	minerals	in	therapeutics.	Raising	safety	issues	 regarding	 ancient	 preparations,	 the	 World	Health	Organization	has	 issued	pointers	concerning	toxicity	studies	of	seasoning	medicine	(13).	
Bhasmas	required	better	purification	There	is	varied	the	importance	of	Bhasma	like	main-taining	optimum	alkalinity	for	optimum	health,	neu-tralizing	harmful	acids	that	result	in	illness;	as	a	re-sult	 of	 Bhasma	 don't	 get	metabolized	 in	 order	 that	they	 do	 not	 produce	 any	 harmful	 matter,	 rather	 it	breakdowns	serious	metals	within	the	body.	ways	to-gether	with	for	Bhasma	preparation	are	parpati,	ra-sayoga,	sindora	etc.	Bhasma	that	contain	iron,	Cu,	S	or	alternative	 producing	method	 plays	 a	 selected	 role	within	 the	 final	product(13).	 Particle	 size	 (1-2	μ)	 re-duced	 considerably,	which	 can	 facilitate	 absorption	and	 assimilation	 of	 the	 drug	 into	 the	 body	 system.	
Standardization	 of	 Bhasma	 is	 utmost	 necessary	 to	verify	its	identity	and	to	work	out	its	quality,	purity	safety,	effectiveness	and	satisfactoriness	of	the	prod-uct.	however,	the	foremost	vital	challenges	visage	by	these	 formulations	 are	 the	 shortage	 of	 complete	standardization	by	physiochemical	parameters	(14).	
Chandraprabha	vati	Chandraprabha	vati	 is	 associate	 ayurvedic	 formula-tion.	These	classical	medicines	ought	to	be	exactly	an-alyzed	before	application	to	the	patient	for	obtaining	a	 fascinating	outcome.	There	are	numbers	of	multi-drug	formulations	practiced	in	ayurveda	clinics	with	success	however	most	of	them	are	anguish	from	lack	of	knowledge	relating	to	their	details	mechanism	of	action.	Such	one	wide	practiced	formulation	is	Chan-draprabha	vati	(16).	The	drug	has	been	mentioned	in	Rasaratnasamucchaya	within	 the	 context	 of	 Kustha	(skin	 disorder)	 and	 in	 Bhaishyajyaratnavali	 within	the	context	of	Yakritvikara	(liver	disorder)	(15).	This	ancient	formulation	of	ayurveda	is	victimization	for	 hundreds	 of	 years	 with	 claimed	 effectivity	 and	safety	 in	treatment	of	 jaundice	and	alternative	 liver	and	skin	disorders	(18).	it's	used	for	Hansen's	disease,	fever,	oedema,	obesity,	 jaundice	and	alternative	he-patic	 disorders.	 The	 drug	 is	 additionally	 smart	 for	lack	of	appetence,	upset	stomach	and	irregular	bowls,	liver	disorders	and	skin	diseases.	It	acts	as	an	alter-nate,	carminative	stomachic	(19).	
Table 1: Composition of Chandraprabha vati 
Sl.	
No.	 Latin	Name	 Sanskrit	Name	1	 Asphaltum	 Shilajit	2	 Commiphora	mukul	 Guggul	4	 Sugar	 Sharkara	3	 Cinnamomum	camphora	 Karpoor	5	 Acorus	calamus	 Vacha	6	 Cyprus	rotundus	 Mustak	7	 Curcuma	longa	 Haridra	8	 Emblica	officinalis	 Amalaki	(Amla)	9	 Piper	chaba	 Chavya	10	 Embelia	ribes	 Vidanga	11	 Tinospora	cordifolia	 Guduchi	(Giloy)	12	 Zingiber	officinalis	 Shunthi	13	 Piper	nigrum	 Maricha	14	 Piper	longum	 Pippali	15	 Sodium	carbonate	 Sarjikashaar	16	 Potassium	carbonate	 Yavkshaar	17	 Rock	salt	 Saindhav	Lavan	18	 Sodium	sulphate	 Suvarchal	Lavan	19	 Black	salt	 Vida	Lavan	20	 Baliospermum	montanum	 Danti	21	 Cinnamomum	zeylanicum	 Dalchini	22	 Cinnamomum	tamala	 Tejpatta	23	 Elettaria	cardamomum	 Ela	
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MATERIALS	AND	METHODS	Chandraprabha	 vati	 (B.R.)	 Manufactured	 by	 Divya	pharmacy,	 Uttarakhand,	 India.	 Chandraprabha	 vati	manufactured	from	Shree	Baidyanadh	Ayurveda	Bha-wan	(P)	LTD,	India.	Was	procured	from	native	medi-cal	stores	glucose	kit,	cholesterol	kit,	Total	protein	kit,	Creatinine	 kit,	 hemoglobin	 kit,	 alkaline	 Phosphates	kit,	amino	acid	transaminase	kit,	Aspartate	transami-nase	are	procured	from	biomedical	LTD.,	Solan,	India.	albumin	 kit	 manufactured	 by	 Agappe	 diagnostics	LTD.,	Kerala,	India.	
Animals:	 Healthy	 man	 and	 female	 rats	 of	 Wistar	strain	 (180-220	 g)	 were	 obtained	 from	 the	 animal	house	 facility	of	Mahati	 college	of	Pharmacy,	Mada-napalle.	The	animals	were	kept	in	a	very	well-venti-lated	room	and	therefore	the	animals	had	exposed	to	12hours	day	and	night	cycle	with	a	temperature	be-tween	20±3ºC.	The	animals	were	housed	in	massive	spacious,	sanitary	polypropene	cages	throughout	ex-perimental	period.	The	animals	were	fed	with	water	and	rat	pellet	 feed	supplied	by	Sree	Venkateshwara	agencies,	Bengaluru,	India.	All	the	experiments	were	performed	 after	 getting	 previous	 approval	 from	CPCSEA	 and	 IAEC	 (registration	 NO:	1952/PO/Re/S/17/CPCSEA/MCP/2018/02-P-COL/DATED	01/05/2018.)	
Mechanism	of	toxicity	of	bhasma	preparations	They	accumulate	and	thereby	disrupt	operate	in	im-portant	organs	and	glands	like	the	heart,	brain,	kid-neys,	bone,	liver,	etc.	They	 displace	 the	 important	 nutritional	 minerals	from	 their	 original	 place,	 thereby,	 obstructive	 their	biological	 function.	 It	 is,	 however,	 not	 possible	 to	measure	 in	 an	 surroundings	 freed	 from	 significant	metals.	There	ar	some	ways	by	that	these	toxins	are	often	 introduced	 into	 the	body	 like	 consumption	of	foods,	beverages,	skin	exposure,	and	also	the	inhaled	air.	As	per	ayurveda,	the	bioavailability	and	toxicity	of	the	metals	 rely	 on	 their	 chemical	 forms,	 particularly	 of	mercury,	 though	 some	authors	 couldn't	 ascertain	 it	by	experimentation.	Heavy	metals	could	exert	their	acute	and	chronic	ef-fects	on	the	human	skin	through	stress	signals.	Find-ings	recommend	that	significant	metals	reduced	the	phosphorylation	 level	 of	 tiny	 heat	 shock	 protein	27(HSP27),	which	 the	 ratio	 of	 p-HSP27	 and	HSP27	could	also	be	a	sensitive	marker	or	further	end	point	for	the	hazard	assessment	of	potential	skin	irritation	caused	by	chemicals	and	their	product	(18).	Bhasmas	and	Rasa,	might	not	have	understood	that	the	standard	formulation	contained	significant	met-als	requiring	special	care	and	oversight.	Inhalation	of	mercury	 vapour	 produces	 acute	 corrosive	 respira-tory	illness	and	opening	inflammation	and,	if	not	fa-tal,	could	also	be	related	to	central	system	nervous	ef-fects	like	tremor	or	accrued	excitability	(18,19)	
RESULTS	AND	DISCUSSION	Chandraprabha	 vati	 could	 be	 an	 ancient	 Ayurvedic	formulation	 used	 for	 centuries	with	 claimed	 effica-ciousness	and	safety	in	treatment	of	jaundice	and	al-ternative	liver	and	skin	disorders.(26)	the	utilization	of	those	metals	in	Ayurvedic	medicines	are	done	after	a	rigorous	 method	 of	 purification	 (Shodhana)	 and	changing	the	metal	into	compounds	(Marana).	How-ever,	 recently	 some	 gold	 preparations	 employed	 in	Indian	system	of	drugs	are	suspected	to	be	harmful,	inflicting	 hepatic,	 nephritic	 and	 neurotoxicity	 and	plenty	of	alternative	side	effects.(27)	so	as	to	know	the	potential	 toxicities	 of	 the	 wide	 marketed	 prepara-tions,	a	sub-acute	toxicity	had	been	conducted.	
Acute	toxicity	study	(OCED	423)	The	acute	toxicity	study	was	performed	by	acute	toxic	classic	methodology.	The	physiological	observational	battery	of	 tests	 shown	 that	 the	 formulation	doesn’t	show	any	deadly	symptoms	up	to	500	mg/kg	for	up	to	14	days	in	albino	Wistar	rats.	
Effect	of	Chandraprabha	vati	on	body	weight	In	toxicity	study,	in	all	groups	at	variable	test	doses,	a	substantial	 significant	 increase	 in	 body	weight	was	evident.	Body	weight	was	indicative	of	increase	appe-tence	 and	 food	 intake	 and	 effectiveness	 of	 a	 drug	might	become	expressed	as	increase	in	body	weight.	As	there	was	increase	in	body	weight	determined,	it's	going	to	be	likely	that	increase	in	body	weight	at	high-est	dose	level	have	effect	on	animals.	The	results	are	showed	in	(Figure 2)	
 
Figure 2: Effect of Chandraprabha vati on body weight	
Effect	 of	 Chandraprabha	 vati	 on	 food	 consump-
tion	Effect	 of	 Chandraprabha	 vati	 on	 food	 consumption	over	 a	 period	 of	 twenty-eight	 days	 treatment	were	recorded	on	day	one,	3,	6,	8,	10,	12,	14,	16,	18,	20,	22,	24,	 26	 and	 twenty-eight	 within	 the	 treatment	 and	control	groups	and	represented	in	graph.		The	treatment	groups	differ	from	the	control	and	that	they	 exhibit	 amendment	 in	 food	 consumption	throughout	the	study	period.	As	there	was	increase	in	food	intake	it	doesn’t	showed	any	impact	in	animals	
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thus	 it	 is	considerable.	Results	are	estimated	below	(Figure 3)	
 
Figure 3: Effect of Chandraprabha vati on consump-
tion of food	
Effect	 of	 Chandraprabha	 vati	 on	 elevated	 plus	
maze	There	 was	 important	 amendment	 in	 latencies	 of	Chandraprabha	 vati	 treated	 groups	 (50	 and	 500	mg/kg)	as	compared	to	normal	control	on	day	1,14,	and	28.	However,	there	was	significant	(p	<	0.001)	in-crease	 in	mean	 retention	 transfer	 latencies	 on	 day	28th	of	Chandraprabha	vati	 treated	cluster	as	 com-pared	 to	 normal	 control	 cluster	 that	 indicate	 im-provement	 in	 memory	 enhancement.	 The	 heavy	metal	 (Hg)	 poisoning	happens	by	deposition	 in	 hu-man	 animal	 tissue	 neuron	 and	 in	 a	 very	 scattered	cluster	of	neurons	within	the	brain	stem	and	neural	structure	by	generation	of	free	radicals,	unleash	of	in-tracellular	 calcium,	 lysosomal	enzyme	or	 cytoskele-ton	disorganization.	The	was	no	amendment	deter-mined	in	Chandraprabha	treated	cluster	the	latency	time	was	estimated	below	(Figure 4Figure 2)	
 
Figure 4: Effect of Chandraprabha vati on elevated 
plus maze	Behavioural	 and	 spatial	 learning	deficits	 in	 animals	due	 to	 consumption	 of	 bhasmas	 containing	 unpro-cessed	heavy	metals	 (Hg)	did	not	 showed	cognitive	impairment	 in	 Chandraprabha	 vati	 consumed	 rats	and	 there	 was	 increased	 ability	 to	 learning	 in	 ele-vated	pulse	maze.	
Effect	of	Chandraprabha	vati	on	rota	rod	Chandraprabha	 vati	 (50	 and	 500	 mg/kg)	 treated	groups	show	significant	amendment	within	the	time	
spent	on	the	spindle	of	the	rota	rod	as	compared	to	normal	control	cluster	on	day	1,	14,	and	28.	However,	there	was	significant	decrease	in	time	spent	on	spin-dle	of	Chandraprabha	vati	treated	cluster	on	day	28th	compared	 to	 regulate	 cluster	 that	 showed	motor	 in	coordination	(p	>	0.001).	(Figure 5)	
 
Figure 5: Effect of Chandraprabha vati on rota rod	The	α-2-adrenergic	receptor	agonists	produce	varia-ble	 levels	 of	 sedation,	 analgesia,	 muscle	 relaxation,	and	anxiolysis.	The	rota	rod	check	assesses	motor	co-ordination	and	balance.	Intact	(healthy)	animals	are	going	 to	 be	 able	 to	 stay	 on	 the	 rotating	 rod	 for	 ex-tended	periods	due	 to	preserved	 limb	 coordination	and	 balance.	 In	 contrast,	 animals	with	 neurological	alterations	 or	 receiving	 neurotoxin	 compounds	 or	sedatives	usually	show	shorter	latencies	to	fall.	In	our	study,	rats	that	treated	with	the	heavy	metal	canting	bhasmas	displayed	significant	difference	in	latency	to	fall	compared	to	intact	rats.	Motor	 coordination	 deficits	 in	 animals	 due	 to	 con-sumption	of	bhasmas	containing	heavy	metals	 (Hg)	did	not	Showed	in	coordination	of	mussels	in	Chan-draprabha	 vati	 consumed	 rats	 and	 there	 was	 no	change	in	ability	to	stay	on	rota	rod.	
Effect	of	Chandraprabha	vati	on	hemoglobin	In	toxicity	study,	in	all	groups	at	varied	test	doses	of	Chandraprabha	vati	treated	groups	shows	a	substan-tial	significant	decrease	in	hemoglobin	levels	as	com-pared	to	normal	control	group.	As	there	was	decrease	in	hemoglobin	levels	determined,	it	should	be	likely	that	 decrease	 in	 hemoglobin	 levels	 at	 highest	 dose	level	have	no	result	on	animals.	Results	was	demon-strated	below	(Figure 6)	
 
Figure 6: Effect of Chandraprabha vati on haemoglo-
bin	
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There	was	significant	change	in	Chandraprabha	vati	treated	groups	(50	and	500	mg/kg)	as	compared	to	normal	control	on	day	1,	14	and	28.	However,	there	was	significant	(p	<	0.001)	decrease	in	hemoglobin	on	day	28th	of	Chandraprabha	vati	treated	group	as	com-pared	to	normal	control	group	which	didn’t	show	ef-fect	on	animals.	
Effect	of	Chandraprabha	vati	on	hematocrit	The	hematocrit	of	blood	determines	 the	percentage	of	red	blood	cells	(RBC's)	in	the	blood.	Blood	is	com-posed	mainly	of	red	blood	cells	and	white	blood	cells	suspended	in	an	almost	clear	fluid	called	serum.	The	hematocrit	indicates	the	percentage	of	blood	by	vol-ume	that	is	composed	of	red	blood	cells.	The	condi-tion	called	"anaemia"	results	from	having	too	few	red	blood	cells.	Results	were	showed	below	(Figure 7)	
 
Figure 7: Effect of Chandraprabha vati on Hematocrit	In	all	groups	the	blood	collections	after	the	beginning	of	treatments	that	is,	day	1,	14	and	28,	the	hematocrit	(HCT,	zip	packed	red	blood	cells),	of	Chandraprabha	vati-treated	groups	showed	minute	changes	relative	to	the	control	group.	At	the	end	of	the	study,	the	total	reductions	in	HCT	were	determined	respectively.	sig-nificant	(p	<	0.001)	amendment	all	told	groups	at	var-ied	test	doses	of	Chandraprabha	vati	treated	groups	shows	 a	 considerable	 significant	 amendment	 in	Hb	levels.	
Effect	of	Chandraprabha	vati	on	platelet	count	A	platelet	count	was	to	measure	how	many	platelets	are	present	in	blood.	Platelets	are	parts	of	the	blood	that	helps	the	blood	clot.	They	are	smaller	than	red	or	white	blood	cells.	Platelets	are	produced	in	the	bone	marrow	and	released	into	the	blood	where	they	play	an	 important	 role	 in	 coagulation	 (blood	 clotting),	helping	to	stop	bleeding	when	blood	vessels	are	 in-jured.	The	results	were	demonstrated	below	(Figure 
8)		The	observed	platelets	count	of	Chandraprabha	vati	treated	group	that	is	1,	14	and	28	days	did	not	show	significant	(p	<	0.001)	change	in	platelet	count	caused	by	Chandraprabha	vati	may	not	be	effectible	to	ani-mals.	So	the	doses	of	the	Chandraprabha	vati	treated	groups	are	considerable.	
	
 
Figure 8: Effect of Chandraprabha vati on platelet 
count	
Effect	of	Chandraprabha	vati	on	sodium	levels	Among	 the	 observations	 of	 test	 group	 of	 rats	 was	finding	 that,	 the	 results	 of	 their	 ability	 to	 conserve	water,	was	normal	in	all	the	groups.	There	was	no	de-hydration	proven	by	an	Chandraprabha	vati	treated	animals.		Plasma	 sodium	 concentration	were	 compared	with	normal	 control	 group	 rats	 and	 results	was	 showed	below	(Figure 9)	
 
Figure 9: Effect of Chandraprabha vati on sodium lev-
els	The	observed	significant	reduction	 in	sodium	levels	by	Chandraprabha	vati	treated	group	that	is	1,	14	and	28	days.	The	sodium	levels	significant	(p	<	0.001)	de-crease	caused	by	Chandraprabha	vati	may	not	be	ef-fectible	 to	 animals.	 So,	 the	 doses	 of	 the	 Chan-draprabha	vati	treated	groups	are	considerable.	
Effect	of	Chandraprabha	vati	on	potassium	levels	Rats	which	develop	low	blood	pressures	as	results	of	low	potassium	diet	are	shown	to	possess	down	serum	metal	 levels.	Once	the	blood	pressure	 is	restored	to	normal	by	injection	and	24	hours	feeding	of	metal,	se-rum	 metal	 levels	 conjointly	 return	 to	 traditional.	There	was	no	amendment	within	the	potassium	lev-els	 in	 Chandraprabha	 vati	 treated	 animals.	 Results	was	discussed	below	(Figure 10)	
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Figure 10: Effect of Chandraprabha vati on potassium 
levels	The	observed	significant	reduction	in	potassium	lev-els	by	Chandraprabha	vati	treated	group	that	is	1,	14	and	 28	 days.	 The	 potassium	 levels	 significant	 (p	 <	0.001)	decrease	caused	by	Chandraprabha	vati	may	not	be	effectible	to	animals.	So	the	doses	of	the	Chan-draprabha	vati	treated	groups	are	considerable.	
Effect	of	Chandraprabha	vati	on	glucose	levels	Glucose	is	key	to	keeping	the	mechanisms	of	the	body	in	top	working	order.	When	glucose	levels	are	opti-mal,	 it	 often	goes	unnoticed.	Results	 showed	below	(Figure 11)	
 
Figure 11: Effect of Chandraprabha vati on glucose 
levels	The	observed	significant	reduction	in	Glucose	levels	by	Chandraprabha	vati	treated	group	that	is	1,	14	and	28	days.	The	significant	(p<0.001)	changes	in	glucose	levels	caused	by	Chandraprabha	vati	may	not	be	ef-fectible	 to	 animals.	 So,	 the	 doses	 of	 the	 Chan-draprabha	vati	treated	groups	are	considerable.	
Effect	of	Chandraprabha	vati	on	total	cholesterol	Cholesterol	could	be	a	fatty	substance	that	is	carried	round	the	body	within	the	blood.	The	body	produces	most	 cholesterol	 naturally,	 and	 it	 is	 found	 in	 some	foods.	 Lipoproteins	 carry	 cholesterol	 within	 the	blood.	The	2	main	varieties	that	carry	cholesterol	to	from	 cells	 are	 known	 as	 low	 density	 lipoproteins	(LDL-C)	 and	high-density	 lipoproteins	 (HDL-C).	 Re-sults	was	discussed	below	(Figure 12)	
 
Figure 12: Effect of Chandraprabha vati on total cho-
lesterol	The	observed	significant	change	in	Cholesterol	levels	by	Chandraprabha	vati	 treated	group	that	was	 in	1,	14	and	28	days.	The	significant	(p	<	0.001)	decrease	in	Cholesterol	 levels	 caused	by	Chandraprabha	 vati	cause	low	density	lipoproteins	(LDL-C)	may	not	be	ef-fectible	 to	 animals.	 So,	 the	 doses	 of	 the	 Chan-draprabha	vati	treated	groups	are	considerable.	
Effect	of	Chandraprabha	vati	on	total	creatinine	Creatinine	was	a	waste	product	in	blood	that	comes	from	muscle	activity.	It	was	normally	removed	from	blood	 by	 kidneys,	 but	 when	 kidney	 function	 slows	down,	 the	 creatinine	 level	 rises.	 Results	 were	 dis-cussed	below	(Figure 13)	
 
Figure 13: Effect of Chandraprabha vati on total creat-
inine	The	mean	plasma	levels	of	blood	serum	creatinine	of	Chandraprabha	vati	and	control	groups	did	not	show	statistical	differ	from	day	one,	14	and	28.	The	values	of	creatinine	levels	was	normal	in	all	the	grouped	an-imals.	So,	the	Chandraprabha	vati	did	not	have	an	ef-fect	on	the	animals.	
Effect	of	Chandraprabha	vati	on	total	protein	Proteins	are	important	building	blocks	of	all	cells	and	important	for	body	growth,	development,	and	health.	a	total	protein	test	is	habitually	accustomed	facilitate	value	a	person's	overall	health	standing	and	will	even	be	accustomed	evaluate	conditions	 like	disease,	ne-phrosis,	 absorption,	 cancers	 or	 infections.	 Results	was	discussed	below	(Figure 14)	
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Figure 14: Effect of Chandraprabha vati on total pro-
tein	In	rat’s	total	super	molecule	values	are	normal	within	the	primary	week	of	neonatal	life.	The	humour	pro-tein	levels	of	Chandraprabha	vati	wear	slightly	mini-mized	from	1,	14	and	28	of	more	days	compared	with	the	control	group.	As	there's	modification	in	protein	levels	this	are	not	effectible	to	the	rats.	The	statistical	significant	(p	<	0.001)	decrease	difference	is	consid-erable.		
Effect	of	Chandraprabha	vati	on	albumin	Albumin,	synthesized	in	the	liver,	is	that	the	protein	of	 the	 highest	 concentration	 in	 plasma.	 albumen	transports	 several	 little	molecules	within	 the	blood	(for	 example,	 bilirubin,	 calcium,	 progesterone,	 and	drugs),	and	is	of	prime	importance	in	maintaining	the	osmotic	pressure	of	the	vascular	system.	Results	was	discussed	below	(Figure 15)	
 
Figure 15: Effect of Chandraprabha vati on albumin	The	mean	 levels	 of	 albumin	 of	 Chandraprabha	 vati	and	 control	 groups	were	 statistically	differing	 from	day	 1,	 14	 and	 28.	 However,	 the	 values	 of	 albumin	were	lower	compared	to	the	values	presented	by	the	animals	in	control	group,	but	they	are	in	the	consid-erable	range.	Thus,	there	was	no	statistically	signifi-cant	difference.		
Effect	 of	 Chandraprabha	 vati	 on	 alanine	 amino	
transferase	Proteins	 referred	 to	 as	 enzymes	 facilitate	 the	 liver	break	down	different	proteins	so	your	body	will	ab-sorb	them	a	lot	of	easily.	ALT	is	one	in	all	these	en-zymes.	It	plays	an	important	role	in	metabolism,	the	process	 that	 turns	 food	 into	 energy.	 ALT	 is	 often	found	within	liver	cells.	However,	once	liver	is	dam-
aged	or	 inflamed,	ALT	may	be	 free	 into	your	blood.	This	 causes	humour	ALT	 levels	 to	 rise.	Results	was	discussed	below	(Figure 16)	
 
Figure 16: Effect of Chandraprabha vati on alanine 
amino transferase	The	 Chandraprabha	 vati	 value	 have	 distinction	 be-tween	pre-treatment	and	post	treatment	the	of	days	one,14	 and	 28.ALT	 levels	 were	 decreased	 as	 com-pared	to	control	group	therefore	it	can	be	concluded	significant	(p	<	0.001)	decrease	that	there	has	not	sig-nificant	 impact	 for	ALT	Chandraprabha	vati	 treated	group.	
Effect	of	Chandraprabha	vati	on	aspartate	amino	
transferase	Amino	transferase	(AST)	is	a	catalyst	that’s	present	in	varied	components	of	your	body.	A	catalyst	may	be	a	protein	that	helps	trigger	chemical	reactions	of	body	must	 function.	AST	 is	 found	within	the	highest	con-centrations	 in	 muscles,	 heart,	 red	 blood	 cells,	 and	liver.	 a	 tiny	 low	 quantity	 of	 AST	 was	 generally	 in	blood.	Results	was	discussed	below	(Figure 17)	
 
Figure 17: Effect of Chandraprabha vati on aspartate 
amino transferase	Serum	 AST	 level	 of	 normal	 control	 and	 Chan-draprabha	vati	within	the	days	of	one,	14	and	28	re-spectively	in	normal	vary	as	compared	with	normal	control	 group,	 there	 was	 no	 important	 distinction	within	the	liquid	body	substance	AST	levels	of	treated	Chandraprabha	vati	group.	
Effect	 of	 Chandraprabha	 vati	 on	 alkaline	 phos-
phatase	
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The	alkaline	phosphatase	test	(ALP)	 is	employed	to	assist	observe	liver	disease	or	bone	disorders.	In	con-ditions	affecting	the	liver,	damaged	liver	cells	unleash	accumulated	amounts	of	ALP	into	the	blood.	If	one	or	a	lot	of	them	are	obstructed,	as	an	example	by	a	tu-mour,	then	blood	levels	of	mountain	can	typically	be	high.	Results	was	discussed	below	(Figure 18)	
 
Figure 18: Effect of Chandraprabha vati on alkaline 
phosphatase	Serum	mountain	 level	 of	 normal	 control	 and	 Chan-draprabha	vati	within	the	days	of	1,	14	and	28	sever-ally	 diminished.	 As	 compared	 the	 normal	 control	group,	there	was	no	significant	difference	within	the	body	fluid	ALP	levels	of	treated	Chandraprabha	vati	group.	
Histopathology	in	28	days’	toxicity	study		The	higher	dose	level	and	low	dose	levels	(50mg/kg	and500mg/kg)	of	Chandraprabha	vati	treated	group	did	 not	 show	 any	 significant	 histopathological	changes	within	the	various	organs	when	subjected	to	histopathological	studies	on	termination	of	the	treat-ment	compared	to	the	control	group	rats.	Since	there	was	no	significant	alteration	within	the	histology	of	varied	organs	at	the	higher	dose	level	and	low	dose	treated	 group.	 The	 histopathological	 interpretation	of	 varied	 organs	 of	 the	 higher	 dose	 level	 treated	group	were	represented	in	figure.	
Effect	of	Chandraprabha	vati	on	brain,	 liver	and	
kidney	histology	The	brain,	liver	and	urinary	organ	of	normal	control	and	Chandraprabha	vati	treated	groups	(50,	and	500	mg/kg)	 showed	 normal	 structure.	 However,	 500	mg/kg	 treated	 Chandraprabha	 vati	 treated	 group	showed	expected	toxicities,	i.e.	necrosis	of	neurons	in	brain,	inflammed	periportal	zone	in	liver	and	disrup-tion	 of	 epithelial	 tissue	 in	 proximal	 convoluted	 tu-bules	in	urinary	organ	these	was	under	the	consider-able	range.	
Effect	of	Chandraprabha	vati	on	liver	Effect	of	Chandraprabha	vati	on	kidney	histology:	The	kidney	 of	 normal	 control	 and	 Chandraprabha	 vati	treated	groups	(50	and	500	mg/kg)	showed	normal	cytoarchitecture	(Figure 19).	
 
(a) 
 
(b) 
 
(c) 
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Figure 19: Effect of Chandraprabha vati on liver (a) 
Control; (b) Brand-1 Chandraprabha vati (50mg/kg); 
(c) Chandraprabha vati (500mg/kg); (d) Brand-1 Chan-
draprabha vati (500mg/kg); (e) Brand-2 Chan-
draprabha vati (500mg/kg). Effect	of	Chandraprabha	vati	on	rat’s	liver	histology.	Light	micrograph	of	(a)	control	rat	liver	showing	nor-mal	design.	(b)	and	(d)	Chandraprabha	vati	brand-1	and	2	(50mg/kg/day)	treated	rats	showing	no	histo-pathological	changes.	(c)	and	(e)	Chandraprabha	vati	brand-1	and	a	pair	of	 (500mg/kg/day)	 treated	 rats	showing	minute	vascular,	chronic	and	death	changes	within	the	liver.	
Effect	of	Chandraprabha	vati	on	kidney	Effect	of	Chandraprabha	vati	on	kidney	histology:	The	kidney	 of	 normal	 control	 and	 Chandraprabha	 vati	treated	groups	(50	and	500	mg/kg)	showed	normal	cytoarchitecture	(Figure 20).		Effect	 of	 chronic	 administration	 of	 Chandraprabha	vati	 on	 rat’s	 excretory	 organ	microscopic	 anatomy.	(a)	 The	 kidneys	 of	 normal	 control	 show	 traditional	histologic	 design.	 (b)	 and	 (d)	 Chandraprabha	 vati	brand-	1and	a	pair	 of	 (50	mg/kg/day),	 showing	no	changes.	(c)	and	(e)	Chandraprabha	vati	brand-1	and	a	pair	of	 (500mg/kg/day)	 treated	 rats	 showing	mi-nute	congestion	of	blood	vessels	and	epithelial	tissue	disruption	in	proximal	convoluted	tubules	was	deter-mined.	
 
(a) 
 
(b) 
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Figure 20: Effect of Chandraprabha vati on kidney (a) 
Control (b) Brand-1 Chandraprabha vati (50mg/kg) (c) 
Brand-1 Chandraprabha vati (500mg/kg) (d) Brand-2 
Chandraprabha vati (50mg/kg) (e) Brand-2 Chan-
draprabha vati (500mg/kg)	
Effect	of	Chandraprabha	vati	on	brain	histology	The	brain	of	normal	control	and	Chandraprabha	vati	treated	groups	(50	and	500	mg/kg)	showed	normal	cytoarchitecture	(Figure 21).	
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Figure 21: Effect of Chandraprabha vati on brain (a) 
Control (b) Brand-1 Chandraprabha vati (50mg/kg) (c) 
Brand-1 Chandraprabha vati (500mg/kg) (d) Brand-2 
Chandraprabha vati (50mg/kg) (e) Brand-2 Chan-
draprabha vati (500mg/kg)	Effect	of	Chandraprabha	vati	on	rat’s	brain	histology.	Light	 micrograph	 of	 (a)	 control	 rat	 brain	 showing	normal	 design.	 (b)	 and	 (d)	 Chandraprabha	 vati	brand-1	 and	 a	 pair	 of	 (50mg/kg/day)	 treated	 rats	showing	 no	 histopathological	 changes.	 (c)	 and	 (e)	Chandraprabha	 vati	 brand-1	 and	 a	 pair	 of	(500mg/kg/day)	 treated	 rats	 showing,	 a	 minute	amendment	in	congestion	of	blood	vessels	and	necro-sis	of	Purkinje	cells	of	the	cerebellum.	
	
DISCUSSION	The	treatment	with	Chandraprabha	vati	was	success-ful	 in	 reverting	 the	 medicine	 parameters	 and	 bio-chemical	changes	shows	that	the	thrombocyte	count	was	 considerably	 increased	 in	 rats	 at	 high	 dose	treated	groups.	However,	the	modification	within	the	Hb	count	falls	within	the	low	normal	range.	The	de-crease	within	the	hematocrit	count	might	be	because	of	 hemodynamic	 interaction	 of	 the	 Chandraprabha	vati	constituents	throughout	its	bio	phase.	The	biochemical	parameters	disclosed	that	the	albu-men	 and	 total	 protein	 considerably	 fluctuated,	 this	might	flow	from	to	a	protein	anabolic	impact	that	is	any	proved	by	gentle	to	moderate	decrease	all	told	bi-ochemical	parameters.	The	on	top	of	mentioned	pa-rameters	and	 these	changes	are	within	 the	conven-tional	vary.	the	safety	profile	of	Chandraprabha	vati	is	well	understood	by	the	correlation	of	physical	and	biochemical	parameters.		Thus,	 we	 state	 that	 the	 Chandraprabha	 vati	 is	 at	 a	dose	 of	 500mg/kg	 evidenced	with	 its	 safety	 in	 the	biological	 system.	 The	 histopathology	 of	 brain,	kidney	and	liver	supports	the	toxicity	studies	Acute	and	sub-acute	oral	toxicity	has	been	advocated	as	basic	tests	for	assessing	safety	and	performed	ac-cording	the	rules	of	OECD.	The	acute	toxicity	take	a	look	at	disclosed	that	Chandraprabha	vati	is	safe	up	to	 five	hundred	mg/kg	on	 single	 treatment.	 In	 sub-acute	 toxicity	 study,	 though	 the	body	weights	were	reduced	throughout	breed	period,	there	have	been	no	changes	 of	 body	 weights	 and	 food	 consumption	 in	male	 and	 feminine	 rats	 or	 between	 treatment	 and	control	groups.		All	figures	data	was	expressed	as	Mean	±	SD,	*p<0.05	when	compared	with	control	group	
CONCLUSION	The	Chandraprabha	vati	was	well	tolerated	and	failed	to	turn	out	any	general	organ	or	general	toxicity	up	to	a	 most	 dose	 of	 five	 hundred	 mg/kg/day	 over	 a	amount	 of	 twenty	 eight	 days.	 there	 have	 been	 no	important	 effects	 on	 biochemical	 or	 organ	 weights	and	no	histologic	changes	thought	of	to	be	associated	with	 treatment.	 there	 have	 been	 no	 consistent,	adverse,	 or	 clinically	 relevant	 changes	 in	haematology,	 clinical	 biochemistry	 parameters	(except	albumen	and	total	protein)	on	twenty	eighth	day	 (terminal	 time	 point).	 simple	 protein	 and	 total	protein	 content	 were	 considerably	 reduced	 within	the	 treatment	 teams	 whereas	 compared	 with	 the	management	cluster	however	 the	decrease	 in	 these	values	were	among	the	normal	vary.	there	have	been	no	 determined	 adverse	 effects	 for	 Chandraprabha	vati	 during	 this	 study	 at	 the	 dose	 levels	 fifty,	 and	500mg/kg/day.		From	 the	 encouraging	 results	 obtained	 from	 the	current	 study,	 more	 experiments	 have	 to	 be	compelled	 to	 conduct	 to	 evaluate	 the	 potential	 of	
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Chandraprabha	 vati	 in	 deadly	 conditions,	 and	therefore	the	formulation	are	going	to	be	helpful	for	patients	in	future.	
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